Ana Ugarte
About
Ana Ugarte is a scholar working on Molecular Biology, Pharmacology and Hematology.
According to data from OpenAlex, Ana Ugarte has authored 20 papers receiving a total of 816 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 8 papers in Pharmacology and 4 papers in Hematology. Recurrent topics in Ana Ugarte's work include Phosphodiesterase function and regulation (10 papers), Cholinesterase and Neurodegenerative Diseases (7 papers) and Histone Deacetylase Inhibitors Research (7 papers). Ana Ugarte is often cited by papers focused on Phosphodiesterase function and regulation (10 papers), Cholinesterase and Neurodegenerative Diseases (7 papers) and Histone Deacetylase Inhibitors Research (7 papers). Ana Ugarte collaborates with scholars based in Spain, China and United States. Ana Ugarte's co-authors include Julen Oyarzábal, Ana Garcı́a-Osta, Mar Cuadrado‐Tejedor, Carolina García, Rafael Franco, Obdulia Rabal, Juan A. Sánchez‐Arias, Marta Pérez-González, Ander Estella‐Hermoso de Mendoza and Musheng Xu and has published in prestigious journals such as Blood, Scientific Reports and Journal of Medicinal Chemistry.
In The Last Decade
Ana Ugarte
20 papers receiving 810 citations
Peers
Ana Ugarte
Juan A. Sánchez‐Arias Spain
Elisa Canepa United States
D. Garceau Canada
Hsiu‐Chiung Yang United States
Laura González‐Lafuente Spain
Shasha Bai China
William J. Zavadoski United States
Ingrid Van der Auwera Belgium
Weina Zhu China
Nemat Khan Australia
Citations per year, relative to Ana Ugarte Ana Ugarte (= 1×)
peers
Juan A. Sánchez‐Arias
Countries citing papers authored by Ana Ugarte
Since
Specialization
Citations
This map shows the geographic impact of Ana Ugarte's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ana Ugarte with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ana Ugarte more than expected).
Fields of papers citing papers by Ana Ugarte
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Ana Ugarte. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ana Ugarte. The network helps show where Ana Ugarte may publish in the future.
Co-authorship network of co-authors of Ana Ugarte
This figure shows the co-authorship network connecting the top 25 collaborators of Ana Ugarte. A scholar is included among the top collaborators of Ana Ugarte based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ana Ugarte. Ana Ugarte is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Roncal, Carmen, E. Martínez-Aguilar, Josune Orbe, et al.. (2019). Trimethylamine-N-Oxide (TMAO) Predicts Cardiovascular Mortality in Peripheral Artery Disease. Scientific Reports. 9(1). 15580–15580.
2.
Rabal, Obdulia, Juan A. Sánchez‐Arias, Mar Cuadrado‐Tejedor, et al.. (2019). Multitarget Approach for the Treatment of Alzheimer’s Disease: Inhibition of Phosphodiesterase 9 (PDE9) and Histone Deacetylases (HDACs) Covering Diverse Selectivity Profiles. ACS Chemical Neuroscience. 10(9). 4076–4101.
3.
Rabal, Obdulia, Juan A. Sánchez‐Arias, Mar Cuadrado‐Tejedor, et al.. (2018). Design, synthesis, biological evaluation and in vivo testing of dual phosphodiesterase 5 (PDE5) and histone deacetylase 6 (HDAC6)-selective inhibitors for the treatment of Alzheimer's disease. European Journal of Medicinal Chemistry. 150. 506–524.
4.
Ugarte, Ana, et al.. (2018). Impact of Neurodegenerative Diseases on Drug Binding to Brain Tissues: From Animal Models to Human Samples. Neurotherapeutics. 15(3). 742–750.
5.
Rabal, Obdulia, Juan A. Sánchez‐Arias, Mar Cuadrado‐Tejedor, et al.. (2018). Discovery of in Vivo Chemical Probes for Treating Alzheimer’s Disease: Dual Phosphodiesterase 5 (PDE5) and Class I Histone Deacetylase Selective Inhibitors. ACS Chemical Neuroscience. 10(3). 1765–1782.
6.
Lecumberri, Ramón, Juan A. Sánchez‐Arias, Ana Ugarte, et al.. (2017). Inducing heat shock protein 70 expression provides a robust anti-thrombotic effect with minimal bleeding risk. Thrombosis and Haemostasis. 117(9). 1722–1729.
7.
Rodríguez, José Antonio, Tomás Sobrino, Ana Ugarte, et al.. (2017). CM352 Reduces Brain Damage and Improves Functional Recovery in a Rat Model of Intracerebral Hemorrhage. Journal of the American Heart Association. 6(6).
8.
Guruceaga, Elizabeth, Ibai Tamayo, José Ramón González‐Porras, et al.. (2016). Hsp70 protects from stroke in atrial fibrillation patients by preventing thrombosis without increased bleeding risk. Cardiovascular Research. 110(3). 309–318.
9.
Cuadrado‐Tejedor, Mar, Carolina García, Juan A. Sánchez‐Arias, et al.. (2016). A First-in-Class Small-Molecule that Acts as a Dual Inhibitor of HDAC and PDE5 and that Rescues Hippocampal Synaptic Impairment in Alzheimer’s Disease Mice. Neuropsychopharmacology. 42(2). 524–539.
10.
Sánchez‐Arias, Juan A., Obdulia Rabal, Mar Cuadrado‐Tejedor, et al.. (2016). Impact of Scaffold Exploration on Novel Dual-Acting Histone Deacetylases and Phosphodiesterase 5 Inhibitors for the Treatment of Alzheimer’s Disease. ACS Chemical Neuroscience. 8(3). 638–661.
11.
Rabal, Obdulia, Juan A. Sánchez‐Arias, Mar Cuadrado‐Tejedor, et al.. (2016). Design, Synthesis, and Biological Evaluation of First-in-Class Dual Acting Histone Deacetylases (HDACs) and Phosphodiesterase 5 (PDE5) Inhibitors for the Treatment of Alzheimer’s Disease. Journal of Medicinal Chemistry. 59(19). 8967–9004.
12.
Cuadrado‐Tejedor, Mar, Carolina García, Sara Mederos, et al.. (2015). Concomitant histone deacetylase and phosphodiesterase 5 inhibition synergistically prevents the disruption in synaptic plasticity and it reverses cognitive impairment in a mouse model of Alzheimer’s disease. Clinical Epigenetics. 7(1). 108–108.
13.
Orbe, Josune, Juan A. Sánchez‐Arias, Obdulia Rabal, et al.. (2015). Design, Synthesis, and Biological Evaluation of Novel Matrix Metalloproteinase Inhibitors As Potent Antihemorrhagic Agents: From Hit Identification to an Optimized Lead. Journal of Medicinal Chemistry. 58(5). 2465–2488.
14.
Orbe, Josune, José Antonio Rodríguez, Juan A. Sánchez‐Arias, et al.. (2015). Discovery and Safety Profiling of a Potent Preclinical Candidate, (4-[4-[[(3R)-3-(Hydroxycarbamoyl)-8-azaspiro[4.5]decan-3-yl]sulfonyl]phenoxy]-N-methylbenzamide) (CM-352), for the Prevention and Treatment of Hemorrhage. Journal of Medicinal Chemistry. 58(7). 2941–2957.
15.
Gómez‐Vallejo, Vanessa, Ana Ugarte, Carolina García, et al.. (2015). Pharmacokinetic investigation of sildenafil using positron emission tomography and determination of its effect on cerebrospinal fluid cGMP levels. Journal of Neurochemistry. 136(2). 403–415.
16.
García, Carolina, Ana Ugarte, Martı́n Martı́nez, et al.. (2014). Phosphodiesterase Inhibition in Cognitive Decline. Journal of Alzheimer s Disease. 42(s4). S561–S573.
17.
José‐Eneriz, Edurne San, Xabier Agirre, Obdulia Rabal, et al.. (2014). Inhibition of the Methyltransferase G9a with Small Molecules As a New Therapeutic Strategy for Treatment of Hematological Malignancies. Blood. 124(21). 3532–3532.
18.
Fernández‐Suárez, Diana, Marta Celorrio, José Ignacio Riezu‐Boj, et al.. (2014). The monoacylglycerol lipase inhibitor JZL184 is neuroprotective and alters glial cell phenotype in the chronic MPTP mouse model. Neurobiology of Aging. 35(11). 2603–2616.
19.
Ugarte, Ana, Francisco J. Gil‐Bea, Carolina García, et al.. (2014). Decreased levels of guanosine 3′, 5′‐monophosphate (cGMP ) in cerebrospinal fluid (CSF ) are associated with cognitive decline and amyloid pathology in A lzheimer's disease. Neuropathology and Applied Neurobiology. 41(4). 471–482.
20.
Eizaguirre, I, et al.. (1995). Characteristics of Continuous Esophageal pH-Metering in Infants with Gastroesophageal Reflux and Apparent Life-Threatening Events. European Journal of Pediatric Surgery. 5(3). 136–138.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Juan A. Sánchez‐Arias Breakdown of academic impact, for papers by Elisa Canepa Breakdown of academic impact, for papers by D. Garceau Breakdown of academic impact, for papers by Hsiu‐Chiung Yang Breakdown of academic impact, for papers by Laura González‐Lafuente Breakdown of academic impact, for papers by Shasha Bai Breakdown of academic impact, for papers by William J. Zavadoski Breakdown of academic impact, for papers by Ingrid Van der Auwera Breakdown of academic impact, for papers by Weina Zhu Breakdown of academic impact, for papers by Nemat Khan